These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 27237427

  • 1. Comparison of amorphous states prepared by melt-quenching and cryomilling polymorphs of carbamazepine.
    Guinet Y, Paccou L, Danède F, Willart JF, Derollez P, Hédoux A.
    Int J Pharm; 2016 Jul 25; 509(1-2):305-313. PubMed ID: 27237427
    [Abstract] [Full Text] [Related]

  • 2. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
    Seefeldt K, Miller J, Alvarez-Núñez F, Rodríguez-Hornedo N.
    J Pharm Sci; 2007 May 25; 96(5):1147-58. PubMed ID: 17455346
    [Abstract] [Full Text] [Related]

  • 3. Carbamazepine polymorphism: A re-visitation using Raman imaging.
    Fateixa S, Nogueira HIS, Trindade T.
    Int J Pharm; 2022 Apr 05; 617():121632. PubMed ID: 35245634
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P, Graeser K, Gordon KC, Strachan CJ, Rades T.
    Int J Pharm; 2011 Sep 30; 417(1-2):94-100. PubMed ID: 21182910
    [Abstract] [Full Text] [Related]

  • 6. Quantitative phase analyses through the Rietveld method with X-ray powder diffraction data of heat-treated carbamazepine form III.
    Antonio SG, Benini FR, Ferreira FF, Rosa PC, Paiva-santos Cde O.
    J Pharm Sci; 2011 Jul 30; 100(7):2658-64. PubMed ID: 21259240
    [Abstract] [Full Text] [Related]

  • 7. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
    Hu Y, Macfhionnghaile P, Caron V, Tajber L, Healy AM, Erxleben A, McArdle P.
    J Pharm Sci; 2013 Jan 30; 102(1):93-103. PubMed ID: 23047833
    [Abstract] [Full Text] [Related]

  • 8. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M, Kogermann K, Heinz A, Aaltonen J, Peltonen L, Strachan C, Yliruusi J.
    Eur J Pharm Biopharm; 2009 Jan 30; 71(1):71-9. PubMed ID: 18590816
    [Abstract] [Full Text] [Related]

  • 9. Characterization of melt-quenched and milled amorphous solids of gatifloxacin.
    Hattori Y, Suzuki A, Otsuka M.
    Drug Dev Ind Pharm; 2016 Nov 30; 42(11):1851-6. PubMed ID: 27109418
    [Abstract] [Full Text] [Related]

  • 10. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
    Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T.
    J Pharm Sci; 2005 Sep 30; 94(9):1998-2012. PubMed ID: 16052554
    [Abstract] [Full Text] [Related]

  • 11. Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.
    Trasi NS, Byrn SR.
    AAPS PharmSciTech; 2012 Sep 30; 13(3):772-84. PubMed ID: 22585375
    [Abstract] [Full Text] [Related]

  • 12. Solid-State Reactivity of Mechano-Activated Simvastatin: Atypical Relation to Powder Crystallinity.
    Modhave D, Laggner P, Brunsteiner M, Paudel A.
    J Pharm Sci; 2019 Oct 30; 108(10):3272-3280. PubMed ID: 31173762
    [Abstract] [Full Text] [Related]

  • 13. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K, Veski P, Rantanen J, Naelapää K.
    Eur J Pharm Sci; 2011 Jul 17; 43(4):278-89. PubMed ID: 21575718
    [Abstract] [Full Text] [Related]

  • 14. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW, Löbmann K, Grohganz H, Rades T, Chieng N.
    J Pharm Pharmacol; 2016 Jan 17; 68(1):36-45. PubMed ID: 26663364
    [Abstract] [Full Text] [Related]

  • 15. Origin of two modes of non-isothermal crystallization of glasses produced by milling.
    Chattoraj S, Bhugra C, Telang C, Zhong L, Wang Z, Sun CC.
    Pharm Res; 2012 Apr 17; 29(4):1020-32. PubMed ID: 22173781
    [Abstract] [Full Text] [Related]

  • 16. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT, Laaksonen T, Rades T, Aaltonen J, Peltonen L, Strachan CJ.
    Mol Pharm; 2014 Jan 06; 11(1):234-42. PubMed ID: 24224572
    [Abstract] [Full Text] [Related]

  • 17. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y, Pang W, Lv J, Wang J, Yang C, Guo W.
    J Pharm Biomed Anal; 2017 May 10; 138():302-315. PubMed ID: 28237872
    [Abstract] [Full Text] [Related]

  • 18. Characterization of polymorphic ampicillin forms.
    Baraldi C, Tinti A, Ottani S, Gamberini MC.
    J Pharm Biomed Anal; 2014 Nov 10; 100():329-340. PubMed ID: 25194347
    [Abstract] [Full Text] [Related]

  • 19. Screening for differences in the amorphous state of indomethacin using multivariate visualization.
    Savolainen M, Heinz A, Strachan C, Gordon KC, Yliruusi J, Rades T, Sandler N.
    Eur J Pharm Sci; 2007 Feb 10; 30(2):113-23. PubMed ID: 17169536
    [Abstract] [Full Text] [Related]

  • 20. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin.
    Feng T, Pinal R, Carvajal MT.
    J Pharm Sci; 2008 Aug 10; 97(8):3207-21. PubMed ID: 17990307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.